World Mental Health Day is observed on October 10th every year, with the overall objective of raising awareness on mental health issues around the world and mobilizing efforts in support of mental health. The Day is a reminder that organizations throughout the U.S. and Canada can get behind the effort by learning more about the prevalence and impact of mental health in the workplace. According to Mental Health and Substance Abuse: 2016 Survey Results from the International Foundation, 93% of employers offer some sort of mental health/substance abuse benefits. This support from workplaces is needed not only today but throughout the year—92% of organizations report that their workforce is stressed and 62% said depression is prevalent in their organization.

Mental Health Support in the Workplace: Employers Respond
I spoke with Julie Stich, CEBS, Vice President of Content at the International Foundation more about the topic. “The first step for organizations to take is assessing the mental health issues that actually exist in their workplace,” Julie said. “The next step is creating solutions based on that need.”

Organizations were asked how prevalent specific conditions are in their workplaces. In addition to the 62% that reported depression as prevalent, alcohol addiction (50%), anxiety disorders (50%), sleep deprivation (39%), prescription drug addiction (32%) and nonprescription drug addiction (29%) are also top concerns. Respondents based their answers on prevalence from their general sense, as well as data from health claims, short-and long-term disability, prescription drug claims and absenteeism.Mental Health in Workplace

 

According to the World Health Organization, depression is the leading cause of disability worldwide, so it’s especially important that organizations are starting to recognize its presence in the workplace. Survey respondents predict that 16% of their organizational disability claims can be attributed to mental health/substance abuse issues.

After understanding the prevalence of mental health conditions in the workplace, the most common treatment options organizations are offering include:

  • Outpatient in-person treatment sessions with a medical professional or therapist (84%)
  • Prescription drug therapies (76%)
  • Inpatient hospital/clinic treatment (69%).

To ease the transition back into work duties, organizations offer a variety of return-to-work programs. These most commonly include off- and on-site case management programs and flexible return to work, including shortened schedules and flexible start and stop times.

While recognition of the importance of mental health benefits is more prominent, workers and organizations still face barriers. Thirty-seven percent of organizations note that workers do not acknowledge or are not ready to address their problems. View the full Mental Health and Substance Abuse Benefits: 2016 Survey Results at www.ifebp.org/mentalhealth.


Anne Patterson
Communications Associate at the International Foundation

 

Anne Patterson

Communications Associate at the International Foundation

Favorite Foundation service/product: The innovative member survey efforts and results from the research team.

Benefits-related topics that interest her most: Health care, nontraditional wellness initiatives, employee benefit communication.

Personal Insight: It’s all about balance with Anne. She loves to run and enjoys a good culinary adventure. She’ll jump at the chance to travel or to spend fun times with family and friends, but she’ll also take time to catch her breath with an occasional Netflix binge or diving into a classic novel.

Recommended Posts

Open pharmacy pill containers on a pile of 20 dollar bills.

What the Executive Order Increasing PBM Fee Transparency Means for Employers

Amanda Wilke, CEBS
 

On April 15, 2025, President Trump signed the executive order (EO) “Lowering Drug Prices by Once Again Putting Americans First,” which includes specific actions to be taken by federal agencies to reduce prescription drug costs, improve transparency and increase competition in the […]

GLP-1 Drug Coverage Continues to Rise in Canada 

Rebecca Plier
 

New Survey Data Reveals Prior Authorization or Other Utilization Management Strategies, Eligibility Requirements, Annual Maximum as Leading Cost Control Methods  A new survey report from the International Foundation of Employee Benefit Plans reveals updated Canadian employer coverage and cost-control mechanisms surrounding glucagon-like […]

GLP-1 Drugs Responsible for Over Ten Percent of Annual Claims 

Rebecca Plier
 

New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms   A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]